|
Symbol
|
Z0ALWZ | Z0ASJZ | Z0ATQZ | SKS6LK | RMBXZV | ROMRCH | RMACRV | RMB5TV | Z0CBZZ | MCBRCH | AFVRTQ | ADYGSQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Autocallable Reverse Convertible Defensive worst | Autocallable Reverse Convertible Defensive worst | Autocallable Reverse Convertible Defensive worst | LUKB Softcallable Multi Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti | ZKB Reverse Convertible on worst of Last Look | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible |
|
Sous-jacent
|
Alcon / Galderma Group AG / Siegfried Hldg. AG | Galderma Group AG / Sika AG / Swiss Life Hldg. N | Galderma Group AG / Sandoz Group AG / SIG Combibloc / VAT Group | Galderma Group AG / Novartis AG / Sika AG | Galderma Group AG / Lonza Group N / Roche PS / Sandoz Group AG / Straumann Hldg. AG | Galderma Group AG / Lonza Group N / Sandoz Group AG | Galderma Group AG / Logitech International SA / Swissquote Group Hldg. S.A. / VAT Group | Galderma Group AG / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Accelleron Industries AG / Galderma Group AG | ABB / BKW AG / Galderma Group AG | Adecco Group AG / Galderma Group AG / VAT Group | BKW AG / Galderma Group AG / Lindt & Sprüngli AG PS |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
27.07.2026 | 27.08.2026 | 07.09.2026 | 07.04.2027 | 20.12.2027 | 23.07.2027 | 22.02.2027 | 20.03.2028 | 09.04.2027 | 27.04.2028 | 08.05.2030 | 10.07.2028 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
66,7876 | 186,282 | 12,496 | 174,48 | 61,93 | 419,40 | 28,78 | 43,36 | 52,8375 | 118,80 | 106,47 | 7 282,50 |
| rendement max. p.a. | 903,93% | 221,90% | 7,77% | 28,88% | 5,90% | 7,05% | 5,97% | 6,60% | 5,64% | 9,58% | 7,45% | 8,10% |
| Demande | - | - | - | - | 98,10 | 98,22 | 106,80 | 99,90 | - | 97,72 | 97,63 | 99,52 |
| Offre | - | - | - | - | 99,10 | 99,02 | 108,00 | 100,90 | - | 98,52 | 98,43 | 100,32 |